IL17A and cancer: In contrast, PD-1- and IL-17-expressing Vγ4+ and Vγ6+ T-IELs exhibit pro-tumorigenic functions, indicating the role of the PD-1 co-receptor and IL-17 in supporting cancer progression [181].